APC (laboratory) — LLMpedia

APC (laboratory)
Name	APC (laboratory)
Field	Laboratory science

Contents

APC (laboratory)

Introduction

APC (laboratory) refers to assays and instruments used to quantify, manipulate, or analyze antigen-presenting cell activity and antigen processing components in vitro, in ex vivo tissues, and in clinical specimens. Studies employing APC methods intersect with workflows at institutions such as National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, Harvard University, and Johns Hopkins University and often inform programs at Wellcome Trust, Bill & Melinda Gates Foundation, European Molecular Biology Laboratory, and Cold Spring Harbor Laboratory. Research outputs are published in journals including Nature, Science, Cell, The Lancet, and Journal of Experimental Medicine.

APC assays define cellular functions of dendritic cells, macrophages, B lymphocytes, and other antigen-presenting populations through measurement of antigen uptake, processing, peptide–MHC presentation, and costimulatory signaling. Typical readouts connect to pathways studied by groups at National Cancer Institute, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Broad Institute, and Salk Institute and are interpreted alongside methods developed at Max Planck Society, Karolinska Institutet, Imperial College London, and University of Tokyo. Functional outputs inform translational programs such as vaccine trials overseen by Gavi, the Vaccine Alliance, European Medicines Agency, Food and Drug Administration, and National Health Service.

Foundations of APC research trace to discoveries by scientists associated with institutions like Rockefeller University, Pasteur Institute, University of Cambridge, and University of Oxford during the 20th century, building on immunology advances reported in conferences such as Cold Spring Harbor Laboratory meetings, Gordon Research Conference, and Keystone Symposia. Key conceptual milestones involved work by investigators at The Rockefeller University Hospital, MRC Laboratory of Molecular Biology, Weizmann Institute of Science, and Stanford University School of Medicine, who characterized antigen processing and major histocompatibility complex function that later informed assays used at Veterans Affairs Medical Center and Mayo Clinic. Technological advances emerged from collaborations with companies and centers such as Thermo Fisher Scientific, BD Biosciences, Illumina, and Agilent Technologies and were disseminated through training at Cold Spring Harbor Laboratory and EMBO courses.

APC methods are pivotal in basic studies at National Cancer Institute, Fred Hutchinson Cancer Center, Dana-Farber Cancer Institute, and Scripps Research Institute to dissect tumor immunology, autoimmunity, and infectious disease. Clinical applications inform biomarker discovery in trials run by NIH Clinical Center, European Organisation for Research and Treatment of Cancer, World Health Organization Immunization Program, and pharmaceutical programs at Pfizer, Moderna, GlaxoSmithKline, and AstraZeneca. Diagnostics leveraging APC readouts support pathogen surveillance coordinated with Centers for Disease Control and Prevention, Public Health England, and Chinese Center for Disease Control and Prevention and influence guidelines from World Health Organization committees and advisory boards at Advisory Committee on Immunization Practices.

Common techniques encompass flow cytometry panels standardized at core facilities like those at Stanford Flow Cytometry Facility, MD Anderson Cancer Center, Yale School of Medicine, and University of California, San Francisco; antigen uptake assays adapted from protocols at EMBO Workshop and Cold Spring Harbor Laboratory; peptide–MHC tetramer staining developed in laboratories associated with National Institute of Allergy and Infectious Diseases and University of Pennsylvania; and imaging methods implemented at microscopy centers such as Max Planck Institute for Biophysical Chemistry and Lawrence Berkeley National Laboratory. Protocols incorporate reagents supplied by Sigma-Aldrich, Miltenyi Biotec, Bio-Rad Laboratories, and Beckman Coulter, and computational analysis pipelines from groups at European Bioinformatics Institute, Broad Institute, Wellcome Sanger Institute, and University of California, Santa Cruz.

APC laboratory work follows biosafety frameworks promulgated by Centers for Disease Control and Prevention, World Health Organization, European Centre for Disease Prevention and Control, and national regulators such as Food and Drug Administration and Health Canada. Facilities often align with standards from Occupational Safety and Health Administration, institutional biosafety committees at Massachusetts General Hospital, and guidelines from American Society for Microbiology and American Association of Immunologists. Clinical sample handling, live pathogen work, and genetically modified antigen studies require containment levels determined by advisory bodies at NIH Office of Science Policy and accreditation through agencies such as College of American Pathologists.

Limitations of APC assays noted by investigators at National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, and academic centers including University of California, San Diego and University of Michigan include variability in donor material, antigen source issues highlighted in reports from European Medicines Agency, and reproducibility concerns discussed at meetings like Gordon Research Conference and in editorials in Nature Immunology. Translational hurdles affect collaborations among pharmaceutical industry partners such as Pfizer and Roche and funding agencies including National Science Foundation and National Institute of Allergy and Infectious Diseases.

Category:Laboratory techniques